Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS (Parenthetical)

v3.24.1.u1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Health plan receivable, allowance for credit loss $ 150 $ 150
Related Party    
Accounts payable, other 44,600 44,200
VIE    
Assets to settle obligations 10,500 8,600
Liabilities without recourse to company assets $ 14,900 $ 13,600
Class A Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 800,000,000 800,000,000
Common stock, shares issued (in shares) 119,409,000 116,588,000
Common stock, shares outstanding (in shares) 119,409,000 116,588,000
Class V Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 205,000,000 205,000,000
Common stock, shares issued (in shares) 196,494,000 196,569,000
Common stock, shares outstanding (in shares) 196,494,000 196,569,000